Sports Medicine

, Volume 33, Issue 3, pp 177–186 | Cite as

Use of Nonsteroidal Anti-Inflammatory Drugs Following Exercise-Induced Muscle Injury

Leading Article

Abstract

The objective of this article is to examine the use of NSAIDs for attenuating exercise-induced muscle injuries (EIMI), with an emphasis on their safety and usefulness for improving muscle function and reducing soreness. NSAIDs are some of the most widely consumed medications in the world, and NSAID use as therapy for EIMI has increased dramatically over the last 20 years. However, there is a lack of agreement concerning NSAID effectiveness for this purpose. The lack of consensus about the efficacy of NSAID use in relation to EIMI has spawned a recent interest in sports medicine research regarding NSAIDs.

The application of a variety of methods used to induce, assess and quantify muscle injury has contributed to the inconsistency among the findings regarding the efficacy of NSAIDs for EIMI. Therefore, future studies should focus on the evaluation of muscle injury and function, with the use of better functional measurement tools and more uniformity in the assessment tools used. However, from review of the current literature, it is concluded that NSAID use for brief periods of time is beneficial for short-term recovery of muscle function and is an important laboratory tool for the study of EIMI.

Notes

Acknowledgements

The author thanks Steve Lanier, Dr Erica Jackson, Dr Scott Stevenson, Richard Burke and Scott Kimberly for their assistance in the preparation of this manuscript. No sources of funding were used to assist in the preparation of this manuscript. The author has no conflicts of interest that are directly relevant to the content of this manuscript.

References

  1. 1.
    Wallace J. Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years. Gastroenterology 1997; 112: 1000–16PubMedCrossRefGoogle Scholar
  2. 2.
    Robinson DR. Prostaglandins and the mechanism of action of anti-inflammatory drugs. Am J Med 1983 Oct 31; 75: 26–31PubMedCrossRefGoogle Scholar
  3. 3.
    Vane J. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 1971; 231: 232–5Google Scholar
  4. 4.
    Williams TJ, Peck MJ. Role of prostaglandin-mediated vasodilation in inflammation. Nature 1977; 270: 530–2PubMedCrossRefGoogle Scholar
  5. 5.
    Vane JR, Botting RM. Mechanism of anti-inflammatory drugs. Scand J Rheumatol 1996; 25Suppl. 102: 9–21CrossRefGoogle Scholar
  6. 6.
    Sirois J, Richards JS. Purification and characterization of a novel, distinct isoform of prostaglandin endoperoxide synthase induced by human chorionic gonadotropin in granulose cells of rat preovulatory follicles. J Biol Chem 1992; 267: 6382–8PubMedGoogle Scholar
  7. 7.
    Griffin M. Epidemiology of nonsteroidal anti-inflammatory drug-associated gastrointestinal injury. Am J Med 1998; 104(Suppl. 3A): 23S–9SPubMedCrossRefGoogle Scholar
  8. 8.
    Hernandez-Diaz S, Garcia-Rodriguez G. Epidemiologic assessment of the safety of conventional nonsteroidal anti-inflammatory drugs. Am J Med 2001; 110(Suppl. 3A): 20S–7SPubMedCrossRefGoogle Scholar
  9. 9.
    Koch M, Dezi A, Ferrario F, et al. Prevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. Arch Intern Med 1996; 156: 2321–32PubMedCrossRefGoogle Scholar
  10. 10.
    Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs. N Engl J Med 1999; 340(24): 1888–99PubMedCrossRefGoogle Scholar
  11. 11.
    Perneger TV, Whelton PK, Klag MJ. Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal anti-inflammatory drugs. N Engl J Med 1994; 331: 1675–8PubMedCrossRefGoogle Scholar
  12. 12.
    Farquhar WB, Morgan AL, Azmbraski EJ, et al. Effects of acetaminophen and ibuprofen on renal function in the stressed kidney. J Appl Physiol 1999; 86(2): 598–604PubMedGoogle Scholar
  13. 13.
    Henry D, Page J, Whyte I, et al. Consumption of nonsteroidal anti-inflammatory drugs and the development of functional renal impairment in elderly subjects: results of a case-controlled study. Br J Clin Pharmacol 1997; 44: 85–90PubMedCrossRefGoogle Scholar
  14. 14.
    Sandler D, Burr F, Weinberg C. Nonsteroidal anti-inflammatory drugs and the risk for chronic renal disease. Ann Intern Med 1991; 155: 165–72Google Scholar
  15. 15.
    Page J, Henry D. Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an under-recognized public health problem. Arch Intern Med 2000; 160: 777–84PubMedCrossRefGoogle Scholar
  16. 16.
    Greene GA. Understanding NSAIDs: from aspirin to COX-2. Clin Cornerstone 2001; 3(5): 50–60CrossRefGoogle Scholar
  17. 17.
    Mitchell JA, Akarasereenont P, Thiemermann C, et al. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci U S A 1993; 90: 11693–7PubMedCrossRefGoogle Scholar
  18. 18.
    Cryer B, Feldman M. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs. Am J Med 1998; 104(5): 413–21PubMedCrossRefGoogle Scholar
  19. 19.
    Slatis P, Ruusinen A. Orthopedic diseases and trauma in Finland: trends in consumption of health services 1970–1985. Acta Orthop Scand Suppl 1991; 241: 13–6PubMedGoogle Scholar
  20. 20.
    Asmussen E. Observations on experimental muscular soreness. Acta Rheumatol Scand 1956; 2: 109–16PubMedGoogle Scholar
  21. 21.
    Davies CT, White MJ. Muscle weakness following eccentric work in man. Pflugers Arch 1981; 392: 168–71PubMedCrossRefGoogle Scholar
  22. 22.
    Armstrong RB, Ogilvie RW, Schwane JA. Eccentric exercise-induced injury to rat skeletal muscle. J Appl Physiol 1983; 54: 80–93PubMedGoogle Scholar
  23. 23.
    Lieber RL, Friden J. Morphologic and mechanical basis of delayed-onset muscle soreness. J Am Acad Orthop Surg 2002; 10: 67–73PubMedGoogle Scholar
  24. 24.
    Dedrick ME, Clarkson PM. The effects of eccentric exercise on motor performance in young and older women. Eur J Appl Physiol 1990; 60: 183–6CrossRefGoogle Scholar
  25. 25.
    Manfredi TG, Fielding RA, O’Reilly KP, et al. Plasma creatine kinase activity and exercise-induced muscle damage in older men. Med Sci Sports Exercise 1991; 23: 1028–934Google Scholar
  26. 26.
    Roth SM, Martel GF, Ivey FM, et al. High-volume, heavy-resistance strength training and muscle damage in young and older women. J Appl Physiol 2000; 88(3): 1112–8PubMedGoogle Scholar
  27. 27.
    Roth SM, Martel GF, Ivey FM, et al. Ultrastructural muscle damage in young vs older men after high-volume, heavy-resistance strength training. J Appl Physiol 1999; 86(6): 1833–40PubMedGoogle Scholar
  28. 28.
    Morgan DL, Allen DG. Early events in stretch-induced muscle damage. J Appl Physiol 1999; 87(6): 2007–15PubMedGoogle Scholar
  29. 29.
    Warren GL, Ingalls CP, Lowe DA, et al. What mechanisms contribute to the strength loss that occurs during and in the recovery from skeletal muscle injury. J Orthop Sports Phys Ther 2002; 32: 58–64PubMedGoogle Scholar
  30. 30.
    Leiber RL, Thornell LE, Friden J. Muscle cytoskeletal disruption occurs within the first 15 minutes of cyclic eccentric contraction. J Appl Physiol 1996; 80: 278–84CrossRefGoogle Scholar
  31. 31.
    Patel TJ, Cuizon D, Mathieu-Costello O, et al. Increased oxidative capacity does not protect skeletal muscle fibers from eccentric contraction-induced injury. Am J Physiol 1998; 274 (5 Pt 2): R1300–8PubMedGoogle Scholar
  32. 32.
    Leiber RL, Friden J. Muscle damage is not a function of muscle force but active muscle strain. J Appl Physiol 1993; 74: 520–6Google Scholar
  33. 33.
    Leiber RL, Friden J. Selective damage of fast glycolytic muscle fibres with eccentric contraction of the rabbit tibialis anterior. Acta Physiol Scand 1998; 133: 587–8CrossRefGoogle Scholar
  34. 34.
    Gibala MJ, MacDougal JD, Tarnopolsky MA, et al. Changes in human skeletal muscle ultrastructure and force production after acute resistance exercise. J Appl Physiol 1995; 78: 702–8PubMedGoogle Scholar
  35. 35.
    Lieber RL, Woodburn TM, Friden J. Muscle damage induced by eccentric contractions of 25% strain. J Appl Physiol 1991; 70: 2498–507PubMedGoogle Scholar
  36. 36.
    O’Reilly KP, Warhol MJ, Fielding RA, et al. Eccentric exercise-induced muscle damage impairs muscle glycogen repletion. J Appl Physiol 1987; 63: 252–6PubMedGoogle Scholar
  37. 37.
    McBride TA, Stockert BW, Gorin FA, et al. Stretch-activated ion channels contribute to membrane depolarization after eccentric contractions. J Appl Physiol 2000; 88: 91–101PubMedGoogle Scholar
  38. 38.
    Grounds MD. Phagocytosis of necrotic muscle in muscle isografts is influenced by the strain, age, and sex of host mice. J Pathol 1987; 153: 71–82PubMedCrossRefGoogle Scholar
  39. 39.
    MacIntyre DL, Reid WD, McKenzie DC. Delayed muscle soreness: the inflammatory response to muscle injury and its clinical implications. Sports Med 1995; 20: 24–40PubMedCrossRefGoogle Scholar
  40. 40.
    Tidball JG. Inflammatory cell response to acute muscle injury. Med Sci Sports Exerc 1995; 27: 1022–32PubMedCrossRefGoogle Scholar
  41. 41.
    Friden J, Leiber RL. Segmental muscle fiber lesions after repetitive eccentric contractions. Cell Tissue Res 1998; 293: 165–71PubMedCrossRefGoogle Scholar
  42. 42.
    Malmsten CL. Prostaglandins, thromboxanes, and leukotrienes in inflammation. Am J Med 1986; 80: 11–7PubMedCrossRefGoogle Scholar
  43. 43.
    Hurley JV. Acute inflammation. New York: Churchill Livingstone, 1983Google Scholar
  44. 44.
    Ferreira SH. Prostaglandins, aspirin-like drugs and analgesia. Nature 1972; 240: 200–3CrossRefGoogle Scholar
  45. 45.
    Rodemann HP, Waxman K, Goldberg L. The stimulation of protein degradation in muscle by Ca2+ is mediated by prostaglandin E2 and does not require the calcium-activated protease. J Biol Chem 1982; 257: 8716–23PubMedGoogle Scholar
  46. 46.
    Ebbeling CB, Clarkson PM. Exercise induced muscle damage and adaptation. Sports Med 1989; 7: 207–34PubMedCrossRefGoogle Scholar
  47. 47.
    Peeze Binkhorst FM, Slaaf DW, Kuipers H, et al. Exercise-induced swelling of rat soleus muscle: its relationship with intramuscular pressure. J Appl Physiol 1990; 69: 67–73PubMedGoogle Scholar
  48. 48.
    Warren GL, Lowe DA, Hayes DA, et al. Excitation failure in mouse soleus muscle injured by eccentric contractions. J Physiol 1993; 468: 487–99PubMedGoogle Scholar
  49. 49.
    Balnave CD, Davey DF, Allen DG. Distribution of sarcomere length and intracellular calcium in mouse skeletal muscle following stretch-induced injury. J Physiol 1997; 502: 649–59PubMedCrossRefGoogle Scholar
  50. 50.
    Ingalls CP, Warren GL, Williams JH, et al. E-C coupling failure in mouse EDL muscle after in vivo eccentric contractions. J Appl Physiol 1998; 85: 58–67PubMedGoogle Scholar
  51. 51.
    Warren GL, Ingalls CP, Shah SJ, et al. Uncoupling of in vivo torque production from EMG in mouse muscle injured by eccentric contractions. J Physiol 1999; 515: 609–19PubMedCrossRefGoogle Scholar
  52. 52.
    Warren GL, Lowe DA, Armstrong RB. Measurement tools used in the study of eccentric contraction-induced injury. Sports Med 1999; 27(1): 43–59PubMedCrossRefGoogle Scholar
  53. 53.
    Baldwin AC, Stevenson SW, Dudley GA. Non-steroidal anti-inflammatory therapy after eccentric exercise in healthy older individuals. J Gerontol A Biol Sci Med Sci 2001; 56(8): M510–3PubMedCrossRefGoogle Scholar
  54. 54.
    Barlas P, Craig JA, Robinson J, et al. Managing delayed-onset muscle soreness: lack of effect of selected oral systemic analgesics. Arch Phys Med Rehabil 2000; 81: 966–72PubMedCrossRefGoogle Scholar
  55. 55.
    Bourgeois J, MacDougall D, MacDonald J, et al. Naproxen does not alter indices of muscle damage in resistance-exercise trained men. Med Sci Sports Exerc 1999; 31: 4–9PubMedCrossRefGoogle Scholar
  56. 56.
    Donnelly AE, McCormick K, Maughan RJ, et al. Effects of a non-steroidal anti-inflammatory drug on delayed onset muscle soreness and indices of damage. Br J Sports Med 1988; 22: 325–8CrossRefGoogle Scholar
  57. 57.
    Donnelly AE, Maughan RJ, Whiting PH. Effects of ibuprofen on exercise-induced muscle soreness and indices of muscle damage. Br J Sports Med 1990; 24: 191–5PubMedCrossRefGoogle Scholar
  58. 58.
    Dudley GA, Czerkawski J, Meinrod A, et al. Efficacy of naproxen sodium for exercise-induced dysfunction, muscle injury and soreness. Clin J Sport Med 1997; 23: 1–6CrossRefGoogle Scholar
  59. 59.
    Francis KT, Hoobler T. Effects of aspirin on delayed muscle soreness. J Sports Med 1987; 27: 333–7Google Scholar
  60. 60.
    Hasson SM, Daniels JC, Divine JG, et al. Effect of ibuprofen use on muscle soreness, damage, and performance: a preliminary investigation. Med Sci Sports Exerc 1993; 25: 9–17PubMedCrossRefGoogle Scholar
  61. 61.
    Kuipers H, Keizer HA, Verstappen FTJ, et al. Influence of a prostaglandin-inhibiting drug on muscle soreness after eccentric work. Int J Sports Med 1985; 6: 336–9PubMedCrossRefGoogle Scholar
  62. 62.
    Lecomte JM, Lacroix VJ, Montgomery DL. A randomized controlled trial of the effect of naproxen on delayed onset muscle soreness and muscle strength. Clin J Sports Med 1998; 8(2): 82–7CrossRefGoogle Scholar
  63. 63.
    Lapointe BM, Fremont P, Cote CH. Adaptation to lengthening contractions is independent of voluntary muscle recruitment but relies on inflammation. Am J Physiol Regul Integr Comp Physiol 2002; 282(1): R323–9PubMedGoogle Scholar
  64. 64.
    Mishra DK, Friden J, Schmitz MC, et al. Anti-inflammatory medication after muscle injury: a treatment resulting in short-term improvement but subsequent loss of muscle function. J Bone Joint Surg 1995; 77(10): 1510–9PubMedGoogle Scholar
  65. 65.
    O’Grady M, Hackney AC, Schneider K, et al. Diclofenac sodium (Voltaren) reduced exercise-induced injury in human skeletal muscle. Clin Sci 1999; 32(7): 1191–6Google Scholar
  66. 66.
    Pizza FX, Cavender D, Stockard A, et al. Anti-inflammatory doses of ibuprofen: effect on neutrophils and exercise-induced muscle injury. Int J Sports Med 1999; 20(2): 98–102PubMedGoogle Scholar
  67. 67.
    Sayers SP, Knight CA, Clarkson PM, et al. Effect of ketoprofen on muscle function and sEMG activity after eccentric exercise. Med Sci Sports Exerc 2000; 33(5): 702–10Google Scholar
  68. 68.
    Semark A, Noakes TD, St Clair A, et al. The effect of a prophylactic dose of flurbiprofen on muscle soreness and sprinting performance in trained subjects. J Sports Sci 1999; 17(3): 197–203PubMedCrossRefGoogle Scholar
  69. 69.
    Fiatarone MA, Evans WJ. The etiology and reversibility of muscle dysfunction in the aged. J Gerontol 1993; 48: 77–83PubMedCrossRefGoogle Scholar
  70. 70.
    Miles MP, Clarkson PM. Exercise-induced muscle pain, soreness, and cramps. J Sports Med Phys Fitness 1994; 34: 203–16PubMedGoogle Scholar
  71. 71.
    Newham DJ, McPhail G, Mills KR, et al. Ultrastructural changes after concentric and eccentric contractions of human muscle. J Neurol Sci 1983; 61: 109–22PubMedCrossRefGoogle Scholar
  72. 72.
    Ploutz-Snyder LL, Tesch PA, Dudley GA. Increased vulnerability to eccentric exercise-induced dysfunction and muscle injury after concentric training. Arch Phys Med Rehabil 1998; 79: 58–61PubMedCrossRefGoogle Scholar
  73. 73.
    Nosaka K, Sakamoto K, Newton M, et al. How long does the protective effect on eccentric exercise-induced muscle damage last? Med Sci Sports Exerc 2000; 33(9): 1490–5Google Scholar
  74. 74.
    Clarkson PM, Ebbeling C. Investigations of serum creatine kinase variability after muscle-damaging exercise. Clin Sci 1988; 75: 257–61PubMedGoogle Scholar
  75. 75.
    Hortobagyi T, Denahan T. Variability in creatine kinase: methodological, exercise, and clinically related factors. Int J Sports Med 1989; 10: 69–80PubMedCrossRefGoogle Scholar
  76. 76.
    Meltzer HY. Factors affecting serum creatine phosphokinase levels in the general population: the role of race, activity, and age. Clin Chim Acta 1971; 33: 165–72PubMedCrossRefGoogle Scholar
  77. 77.
    Jones DA, Newham DJ, Round JM, et al. Experimental human muscle damage: morphological changes in relation to other indices of damage. J Appl Physiol 1986; 375: 435–48Google Scholar
  78. 78.
    Evans GF, Haller RG, Wyrick PS, et al. Submaximal delayed-onset muscle soreness: correlations between MR imaging findings and clinical measures. Radiology 1998; 208(3): 815–20PubMedGoogle Scholar
  79. 79.
    Fleckenstein JL, Canby RC, Parkey RW, et al. Acute effects of exercise on MR imaging of skeletal muscle in normal volunteers. Am J Roentgenol 1988; 151(2): 231–7Google Scholar
  80. 80.
    Fleckenstein JL, Peshock RM, Lewis SL, et al. Magnetic resonance imaging of muscle injury and atrophy in glycolytic myopathies. Muscle Nerve 1989; 12: 849–55PubMedCrossRefGoogle Scholar
  81. 81.
    Fleckenstein JL, Weatherall PT, Parkey RW, et al. Sports-related muscle injuries: evaluation with MR imaging. Radiology 1989; 172: 793–8PubMedGoogle Scholar
  82. 82.
    LeBlanc AD, Jaweed M, Evans H. Evaluation of muscle injury using magnetic resonance imaging. Clin J Sports Med 1993; 3: 26–30CrossRefGoogle Scholar
  83. 83.
    Speer KP, Lohnes J, Garrett WE. Radiographic imaging of muscle strain injury. Am J Sports Med 1993; 21: 89–96PubMedCrossRefGoogle Scholar
  84. 84.
    Shellock FG, Fukunaga T, Mink JH, et al. Acute effects of exercise on MR imaging of skeletal muscle: concentric vs eccentric actions. Am J Roentgenol 1991; 156(4): 765–8Google Scholar
  85. 85.
    Takahashi H, Kuno S, Miyamoto T, et al. Changes in magnetic resonance images in human skeletal muscle after eccentric exercise. Eur J Appl Physiol 1994; 69: 408–13CrossRefGoogle Scholar
  86. 86.
    Palmer RM. Prostaglandins and the control of muscle protein synthesis and degradation. Prostaglandins Leukot Essent Fatty Acids 1990; 39: 95–104PubMedCrossRefGoogle Scholar
  87. 87.
    Trappe TA, Fluckey JD, White F, et al. Skeletal muscle PGF2a and PGE2 in response to eccentric resistance exercise: influence of ibuprofen and acetaminophen. J Clin Endocrinol Metab 2001; 86(10): 5067–70PubMedCrossRefGoogle Scholar
  88. 88.
    Trappe TA, White F, Lambert CP, et al. Effect of ibuprofen and acetaminophen on postexercise muscle protein synthesis. Am J Physiol Endocrinol Metab 2002; 282: E551–6PubMedGoogle Scholar
  89. 89.
    Thorsson O, Rantanen J, Hurme T, et al. Effects of nonsteroidal antiinflammatory medication on satellite cell proliferation during muscle regeneration. Am J Sports Med 1998; 26(2): 172–6PubMedGoogle Scholar

Copyright information

© Adis Data Information BV 2003

Authors and Affiliations

  1. 1.Department of Health, Physical Education and Sport ScienceKennesaw State UniversityKennesawUSA

Personalised recommendations